Guang Jia1,
Saba N. Elias1, Ronney Abaza2, Debra L. Zynger3,
Zarine K. Shah1, Lai Wei4, Robert R. Bahnson2,
Michael V. Knopp1
1Department
of Radiology, The Ohio State University, Columbus, OH, United States; 2Department
of Urology, The Ohio State University, Columbus, OH, United States; 3Department
of Pathology, The Ohio State University, Columbus, OH, United States; 4Center
for Biostatistics, The Ohio State University, Columbus, OH, United States
This study shows the importance of APT-MRI contrast optimization based on pulse duration and power strength in clinical prostate cancer patient examinations and its benefits to further develop this methodology into an imaging biomarker.